Be part of the knowledge.™

Nephrology

785

LikeLikedUnlike

76-90 of 131

Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
MinuteCE®
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
- Akshay S. Desai, MD
- John McMurray, MD
1.25 program credits
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
CME/CE
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
- David Wheeler, MB, CHB, MD, FRCP
0.25 credits
MinuteCE®
Bridging the Gap: ns-MRAs in Cardiovascular-Kidney-Metabolic Syndrome Care
- Pardeep Jhund, MD, PhD
- Hiddo L. Heerspink, PhD
- John McMurray, MD
- Akshay S. Desai, MD
- Csaba P. Kovesdy, MD
- Finnian R. McCausland, MD
- Orly Vardeny, MD
- Muthiah Vaduganathan, MD, MPH
1.25 credits 10 episodes
MOA Deep Dive: The MRA Spectrum
MinuteCE®
MOA Deep Dive: The MRA Spectrum
- John McMurray, MD
- Hiddo L. Heerspink, PhD
1.25 program credits
Nonsteroidal MRAs: The CKD/T2D Advantage
MinuteCE®
Nonsteroidal MRAs: The CKD/T2D Advantage
- John McMurray, MD
- Pardeep Jhund, MD, PhD
1.25 program credits
Emerging Evidence in HF Care
MinuteCE®
Emerging Evidence in HF Care
- Pardeep Jhund, MD, PhD
- John McMurray, MD
1.25 program credits
advertisement
Nonsteroidal MRAs: The CKD/T1D Potential
MinuteCE®
Nonsteroidal MRAs: The CKD/T1D Potential
- John McMurray, MD
- Hiddo L. Heerspink, PhD
1.25 program credits
Getting to the Root of CKD-Associated Pruritus: Questions From the Field
CME/CE
Getting to the Root of CKD-Associated Pruritus: Questions From the Field
- Joel Topf, MD
- James Burton, DM, FRCP
0.25 credits
Overcoming Clinical Inertia in Hyperkalemia Management
CME/CE
Overcoming Clinical Inertia in Hyperkalemia Management
- Peter Rossing, MD, DMSc
- Michael Böhm, MD
- Luca De Nicola, MD, PhD
0.25 credits
Emerging Therapeutics in ADH1: Progress in Precision Medicine
MinuteCE®
Emerging Therapeutics in ADH1: Progress in Precision Medicine
- Michael A. Levine, MD, FAAP, MACE, FACP
- B. Michelle Schweiger, DO, MPH
1.00 program credits
Therapeutic Options for ADH1 and Hypoparathyroidism
MinuteCE®
Therapeutic Options for ADH1 and Hypoparathyroidism
- Michael A. Levine, MD, FAAP, MACE, FACP
- B. Michelle Schweiger, DO, MPH
1.00 program credits
MinuteCE®
The Future of ADH1 - Looking at Emergent Treatments
- Michael A. Levine, MD, FAAP, MACE, FACP
- B. Michelle Schweiger, DO, MPH
1.00 credits 4 episodes
advertisement
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
MinuteCE®
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
- Michael A. Levine, MD, FAAP, MACE, FACP
- B. Michelle Schweiger, DO, MPH
1.00 program credits
CASR and ADH1: Integrating Biology and Genetic Screening
MinuteCE®
CASR and ADH1: Integrating Biology and Genetic Screening
- Michael A. Levine, MD, FAAP, MACE, FACP
- B. Michelle Schweiger, DO, MPH
1.00 program credits
Ultrasound Renal Denervation: Interdisciplinary Approach to Better Patient Outcomes 
CME/CE
Ultrasound Renal Denervation: Interdisciplinary Approach to Better Patient Outcomes 
- Naomi Fisher, MD
- Florian Rader, MD
0.50 credits

Program Chapters

Segment Chapters

Playlist:

Recommended